Medical Device Technologies, Inc. BioPince Full Core Biopsy Instrument packed in aTyvek/plastic blister pack which is labeled as previously stated and also in a cardboard shelf carton labeled as MDTECH Gainesville, Florida 32608 BioPince FULL CORE BIOPSY INSTRUMENT ga. cm REF: Lot Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
BioPince Full Core Biopsy Instrument packed in aTyvek/plastic blister pack which is labeled as previously stated and also in a cardboard shelf carton labeled as MDTECH Gainesville, Florida 32608 BioPince FULL CORE BIOPSY INSTRUMENT ga. cm REF: Lot
Brand
Medical Device Technologies, Inc.
Lot Codes / Batch Numbers
Not specified in FDA notice. Check official source for details.
Products Sold
PART NUMBER LOT NUMBER 360-1080-01 24821 360-1080-01 30531 360-1080-01 30811 360-1080-01 30923 360-1080-02 24821 360-1080-01 31251 360-1080-01 32211 360-1080-01 32842 360-1080-01 32851-1 360-1080-01 32851-2 360-1080-01 33451 360-1080-01 33452 360-1080-01 33832 360-1080-01 34031 360-1080-01 34331 360-1080-01 34512 360-1080-01 34721 360-1580-01 30633 360-1580-01 31042 360-1580-01 32032 360-1580-01 32341 360-1580-01 32852 360-1580-01 33433 360-1580-01 33434 360-1580-01 34232 360-1580-01 34931 360-1580-01 32852-2 360-2080-01 30751 360-2080-01 30811 360-2080-01 31531 360-2080-01 33331 360-2080-01 33332 360-2080-01 34221 360-2080-01 34322 360-2080-01 34734 360-2080-01 34941 363-1080-01 32431 364-1080-01 34549 364-1580-01 34432 370-1080-01 33932 370-1080-01 35032 370-1580-01 34447 370-1580-01 35021
Medical Device Technologies, Inc. is recalling BioPince Full Core Biopsy Instrument packed in aTyvek/plastic blister pack which is labeled as prev due to The outer plastic blister packagiing material may be cracked thereby compromising the device's sterility barrier.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
The outer plastic blister packagiing material may be cracked thereby compromising the device's sterility barrier.
Recommended Action
Per FDA guidance
The firm mailed a recall letter to accounts on 3/2/2004 asking each account to inspect their in stock product for damage and to to notify the recalling firm and return product. Also the firm enclosed a response card in a self addressed postage paid envelope.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026